Pediatrix Medical Group (MD) Competitors

$21.48 +0.22 (+1.03%)

Closing price 05/26/2026 03:58 PM Eastern

Extended Trading

$21.55 +0.07 (+0.33%)

As of 04:15 AM Eastern

MD vs. CHE, CRVL, AMN, CCRN, and DGX

Should you buy Pediatrix Medical Group stock or one of its competitors? MarketBeat compares Pediatrix Medical Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Pediatrix Medical Group include Chemed (CHE), CorVel (CRVL), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Quest Diagnostics (DGX). These companies are all part of the "health care services" industry.

How does Pediatrix Medical Group compare to Chemed?

Chemed (NYSE:CHE) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

Chemed has a net margin of 10.23% compared to Pediatrix Medical Group's net margin of 9.02%. Chemed's return on equity of 27.18% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.23%	27.18%	17.38%
Pediatrix Medical Group	9.02%	19.94%	8.02%

Chemed currently has a consensus target price of $501.50, suggesting a potential upside of 14.47%. Pediatrix Medical Group has a consensus target price of $22.50, suggesting a potential upside of 4.75%. Given Chemed's stronger consensus rating and higher possible upside, equities analysts plainly believe Chemed is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

95.9% of Chemed shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Chemed has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.30	$265.24M	$18.35	23.88
Pediatrix Medical Group	$1.91B	0.92	$165.39M	$2.06	10.43

Chemed has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

In the previous week, Chemed had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 3 mentions for Chemed and 0 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.33 beat Chemed's score of 0.21 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Chemed	Neutral
Pediatrix Medical Group	Neutral

Summary

Chemed beats Pediatrix Medical Group on 13 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to CorVel?

CorVel (NASDAQ:CRVL) and Pediatrix Medical Group (NYSE:MD) are both health care services companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

In the previous week, CorVel had 11 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 11 mentions for CorVel and 0 mentions for Pediatrix Medical Group. CorVel's average media sentiment score of 0.80 beat Pediatrix Medical Group's score of 0.33 indicating that CorVel is being referred to more favorably in the media.

Company	Overall Sentiment
CorVel	Positive
Pediatrix Medical Group	Neutral

CorVel has a net margin of 11.51% compared to Pediatrix Medical Group's net margin of 9.02%. CorVel's return on equity of 29.92% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
Pediatrix Medical Group	9.02%	19.94%	8.02%

Pediatrix Medical Group has higher revenue and earnings than CorVel. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.26	$110.34M	$2.14	28.53
Pediatrix Medical Group	$1.91B	0.92	$165.39M	$2.06	10.43

Pediatrix Medical Group has a consensus price target of $22.50, suggesting a potential upside of 4.75%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

51.4% of CorVel shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 44.6% of CorVel shares are held by company insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

CorVel has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

Summary

CorVel beats Pediatrix Medical Group on 10 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Pediatrix Medical Group (NYSE:MD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Pediatrix Medical Group has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.39	-$95.70M	-$0.87	N/A
Pediatrix Medical Group	$1.91B	0.92	$165.39M	$2.06	10.43

In the previous week, AMN Healthcare Services had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 2 mentions for AMN Healthcare Services and 0 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.33 beat AMN Healthcare Services' score of -0.25 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company	Overall Sentiment
AMN Healthcare Services	Neutral
Pediatrix Medical Group	Neutral

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Pediatrix Medical Group has a net margin of 9.02% compared to AMN Healthcare Services' net margin of -0.95%. Pediatrix Medical Group's return on equity of 19.94% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Pediatrix Medical Group	9.02%	19.94%	8.02%

AMN Healthcare Services currently has a consensus target price of $25.29, suggesting a potential downside of 7.17%. Pediatrix Medical Group has a consensus target price of $22.50, suggesting a potential upside of 4.75%. Given Pediatrix Medical Group's higher probable upside, analysts clearly believe Pediatrix Medical Group is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

AMN Healthcare Services has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

Summary

Pediatrix Medical Group beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Cross Country Healthcare?

Pediatrix Medical Group (NYSE:MD) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap health care services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Pediatrix Medical Group presently has a consensus price target of $22.50, suggesting a potential upside of 4.75%. Cross Country Healthcare has a consensus price target of $12.72, suggesting a potential downside of 2.75%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, research analysts plainly believe Pediatrix Medical Group is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Pediatrix Medical Group has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market.

Pediatrix Medical Group has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	0.92	$165.39M	$2.06	10.43
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A

In the previous week, Cross Country Healthcare had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 2 mentions for Cross Country Healthcare and 0 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.33 beat Cross Country Healthcare's score of 0.00 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company	Overall Sentiment
Pediatrix Medical Group	Neutral
Cross Country Healthcare	Neutral

Pediatrix Medical Group has a net margin of 9.02% compared to Cross Country Healthcare's net margin of -9.84%. Pediatrix Medical Group's return on equity of 19.94% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	9.02%	19.94%	8.02%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 1.8% of Pediatrix Medical Group shares are owned by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Pediatrix Medical Group beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Quest Diagnostics has a net margin of 9.07% compared to Pediatrix Medical Group's net margin of 9.02%. Pediatrix Medical Group's return on equity of 19.94% beat Quest Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.07%	15.60%	7.06%
Pediatrix Medical Group	9.02%	19.94%	8.02%

Quest Diagnostics has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Quest Diagnostics presently has a consensus target price of $216.58, indicating a potential upside of 12.29%. Pediatrix Medical Group has a consensus target price of $22.50, indicating a potential upside of 4.75%. Given Quest Diagnostics' stronger consensus rating and higher probable upside, equities analysts plainly believe Quest Diagnostics is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

88.1% of Quest Diagnostics shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by company insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Quest Diagnostics has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.28B	1.89	$992M	$9.05	21.31
Pediatrix Medical Group	$1.91B	0.92	$165.39M	$2.06	10.43

In the previous week, Quest Diagnostics had 11 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 11 mentions for Quest Diagnostics and 0 mentions for Pediatrix Medical Group. Quest Diagnostics' average media sentiment score of 0.91 beat Pediatrix Medical Group's score of 0.33 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Quest Diagnostics	Positive
Pediatrix Medical Group	Neutral

Summary

Quest Diagnostics beats Pediatrix Medical Group on 11 of the 16 factors compared between the two stocks.

Get Pediatrix Medical Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MD vs. The Competition

Export

Metric	Pediatrix Medical Group	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.75B	$8.49B	$6.45B	$23.18B
Dividend Yield	N/A	2.98%	2.76%	4.09%
P/E Ratio	10.43	21.26	20.78	31.06
Price / Sales	0.92	19.60	527.11	24.76
Price / Cash	9.51	86.20	43.49	25.06
Price / Book	2.01	5.88	10.40	4.78
Net Income	$165.39M	$183.47M	$3.56B	$1.07B
7 Day Performance	-4.67%	4.52%	2.40%	1.74%
1 Month Performance	-8.17%	8.23%	2.09%	1.35%
1 Year Performance	55.20%	4.08%	35.54%	27.44%

Pediatrix Medical Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MD Pediatrix Medical Group	2.5983 of 5 stars	$21.48 +1.0%	$22.50 +4.7%	+58.8%	$1.75B	$1.91B	10.43	4,315
CHE Chemed	3.9162 of 5 stars	$441.51 0.0%	$501.50 +13.6%	-23.0%	$5.84B	$2.53B	23.99	15,811
CRVL CorVel	1.4104 of 5 stars	$59.43 +0.5%	N/A	-44.7%	$3.04B	$941.49M	29.13	5,075
AMN AMN Healthcare Services	1.4896 of 5 stars	$28.08 -2.7%	$25.29 -9.9%	+31.1%	$1.09B	$3.42B	N/A	2,664	Gap Down
CCRN Cross Country Healthcare	1.9645 of 5 stars	$13.12 +0.1%	$12.72 -3.0%	-3.3%	$424.05M	$1.00B	N/A	6,784

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MD) was last updated on 5/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pediatrix Medical Group (MD) Competitors

MD vs. CHE, CRVL, AMN, CCRN, and DGX

How does Pediatrix Medical Group compare to Chemed?

Summary

How does Pediatrix Medical Group compare to CorVel?

Summary

How does Pediatrix Medical Group compare to AMN Healthcare Services?

Summary

How does Pediatrix Medical Group compare to Cross Country Healthcare?

Summary

How does Pediatrix Medical Group compare to Quest Diagnostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MD vs. The Competition

Pediatrix Medical Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Pediatrix Medical Group (MD) Competitors

MD vs. CHE, CRVL, AMN, CCRN, and DGX

How does Pediatrix Medical Group compare to Chemed?

Is CHE or MD more profitable?

Do analysts prefer CHE or MD?

Do institutionals and insiders hold more shares of CHE or MD?

Which has preferable valuation & earnings, CHE or MD?

Which has more risk & volatility, CHE or MD?

Does the media refer more to CHE or MD?

Summary

How does Pediatrix Medical Group compare to CorVel?

Does the media favor CRVL or MD?

Is CRVL or MD more profitable?

Which has preferable earnings & valuation, CRVL or MD?

Do analysts rate CRVL or MD?

Do institutionals & insiders hold more shares of CRVL or MD?

Which has more volatility and risk, CRVL or MD?

Summary

How does Pediatrix Medical Group compare to AMN Healthcare Services?

Which has better valuation and earnings, AMN or MD?

Does the media refer more to AMN or MD?

Do institutionals and insiders hold more shares of AMN or MD?

Is AMN or MD more profitable?

Do analysts prefer AMN or MD?

Which has more risk and volatility, AMN or MD?

Summary

How does Pediatrix Medical Group compare to Cross Country Healthcare?

Do analysts prefer MD or CCRN?

Which has more risk & volatility, MD or CCRN?

Which has higher earnings & valuation, MD or CCRN?

Does the media refer more to MD or CCRN?

Is MD or CCRN more profitable?

Do insiders and institutionals hold more shares of MD or CCRN?

Summary

How does Pediatrix Medical Group compare to Quest Diagnostics?

Is DGX or MD more profitable?

Which has more volatility & risk, DGX or MD?

Do analysts prefer DGX or MD?

Do institutionals & insiders believe in DGX or MD?

Which has better earnings and valuation, DGX or MD?

Does the media favor DGX or MD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MD vs. The Competition

Pediatrix Medical Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools